Literature DB >> 26609141

Classical and Alternative Activation of Cyanobacterium Oscillatoria sp. Lipopolysaccharide-Treated Rat Microglia in vitro.

Alejandro M S Mayer1, Joseph Murphy2, David MacAdam2, Christopher Osterbauer2, Imaan Baseer2, Mary L Hall3, Domonkos Feher4, Phillip Williams4.   

Abstract

The purpose of this investigation was to test the hypothesis that an in vitro exposure to cyanobacterium Oscillatoria sp. Lipopolysaccharide (LPS) might result in classical and alternative activation of rat neonatal microglia. Using Escherichia coli LPS-primed microglia as a positive control, this study revealed that treatment of rat microglia with Oscillatoria sp. LPS for 17 h in vitro resulted in both classical and alternative activation as well as concomitant pro-inflammatory and anti-inflammatory mediator release, in a concentration-dependent manner: (1) treatment with 0.1-10 000 ng/ml Oscillatoria sp. LPS resulted in minimal lactic dehydrogenase (LDH) release, induced concentration-dependent and statistically significant O2 (-) generation, matrix metalloproteinase-9 (MMP-9) release, generation of the cytokines tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6), and the chemokines macrophage inflammatory protein-2 (MIP-2/CXCL2), interferon γ-induced protein 10 kDa (IP-10/CXCL-10), (MIP-1α/CCL3), monocyte chemotactic protein-1 (MCP-1/CCL2), regulated on activation, normal T cell expressed and secreted (RANTES/CCL5), and the alternative activation cytokine IL-10; (3) in contrast, treatment with 100 000 ng/ml Oscillatoria sp. LPS appeared to damage the microglia cell membrane, because it resulted in minimal O2 (-) generation, statistically significant LDH release, and a decrease in the generation of all the cytokines and chemokines investigated, with the exception of IL-1α and cytokine-induced neutrophil chemoattractant 1 (CINC-1/CXCL1) generation, which was increased. Thus, our results provide experimental support for our working hypothesis, namely that Oscillatoria sp. LPS induces classical and alternative activation of rat brain microglia in vitro in a concentration-dependent manner, namely 0.1-10 000 ng/ml Oscillatoria sp. LPS, when microglia cells were shown to be viable. Furthermore, should cyanobacterium Oscillatoria sp. LPS gain entry into the CNS, our findings suggest that classical and alternative activation of rat brain microglia in vivo, might lead to concomitant mediator release that could result in an interplay between neuroinflammation and neural repair in a concentration-dependent manner.
© The Author 2015. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Oscillatoria; alternative activation; classical activation; cyanobacteria; lipopolysaccharide; microglia; rat

Mesh:

Substances:

Year:  2015        PMID: 26609141      PMCID: PMC4900220          DOI: 10.1093/toxsci/kfv251

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  62 in total

Review 1.  Structure of bacterial lipopolysaccharides.

Authors:  Martine Caroff; Doris Karibian
Journal:  Carbohydr Res       Date:  2003-11-14       Impact factor: 2.104

Review 2.  Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease.

Authors:  Steven J Van Dyken; Richard M Locksley
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

3.  Structural investigation of the antagonist LPS from the cyanobacterium Oscillatoria planktothrix FP1.

Authors:  Sara Carillo; Giuseppina Pieretti; Emiliano Bedini; Michelangelo Parrilli; Rosa Lanzetta; Maria Michela Corsaro
Journal:  Carbohydr Res       Date:  2013-10-23       Impact factor: 2.104

4.  Time course and cellular localization of interleukin-10 mRNA and protein expression in autoimmune inflammation of the rat central nervous system.

Authors:  S Jander; J Pohl; D D'Urso; C Gillen; G Stoll
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

5.  Differential migration, LPS-induced cytokine, chemokine, and NO expression in immortalized BV-2 and HAPI cell lines and primary microglial cultures.

Authors:  Ryan J Horvath; Nancy Nutile-McMenemy; Matthew S Alkaitis; Joyce A Deleo
Journal:  J Neurochem       Date:  2008-09-18       Impact factor: 5.372

6.  Neuroprotective effects of toll-like receptor 4 antagonism in spinal cord cultures and in a mouse model of motor neuron degeneration.

Authors:  Massimiliano De Paola; Alessandro Mariani; Paolo Bigini; Marco Peviani; Giovanni Ferrara; Monica Molteni; Sabrina Gemma; Pietro Veglianese; Valeria Castellaneta; Valentina Boldrin; Carlo Rossetti; Chiara Chiabrando; Gianluigi Forloni; Tiziana Mennini; Roberto Fanelli
Journal:  Mol Med       Date:  2012-09-07       Impact factor: 6.354

Review 7.  Occupational and environmental hazard assessments for the isolation, purification and toxicity testing of cyanobacterial toxins.

Authors:  Ian Stewart; Wayne W Carmichael; Ross Sadler; Glenn B McGregor; Karen Reardon; Geoffrey K Eaglesham; Wasantha A Wickramasinghe; Alan A Seawright; Glen R Shaw
Journal:  Environ Health       Date:  2009-11-19       Impact factor: 5.984

Review 8.  Heterogeneity of microglial activation in the innate immune response in the brain.

Authors:  Carol A Colton
Journal:  J Neuroimmune Pharmacol       Date:  2009-08-05       Impact factor: 4.147

Review 9.  Interleukin-6, a major cytokine in the central nervous system.

Authors:  María Erta; Albert Quintana; Juan Hidalgo
Journal:  Int J Biol Sci       Date:  2012-10-25       Impact factor: 6.580

10.  Microglial VPAC1R mediates a novel mechanism of neuroimmune-modulation of hippocampal precursor cells via IL-4 release.

Authors:  Robert Nunan; Harri Sivasathiaseelan; Damla Khan; Malik Zaben; William Gray
Journal:  Glia       Date:  2014-05-06       Impact factor: 7.452

View more
  15 in total

Review 1.  Microglia: Housekeeper of the Central Nervous System.

Authors:  John Alimamy Kabba; Yazhou Xu; Handson Christian; Wenchen Ruan; Kitchen Chenai; Yun Xiang; Luyong Zhang; Juan M Saavedra; Tao Pang
Journal:  Cell Mol Neurobiol       Date:  2017-05-22       Impact factor: 5.046

2.  Effects of cyanobacteria Oscillatoria sp. lipopolysaccharide on B cell activation and Toll-like receptor 4 signaling.

Authors:  Michelle Swanson-Mungerson; Ryan Incrocci; Vijay Subramaniam; Philip Williams; Mary L Hall; Alejandro M S Mayer
Journal:  Toxicol Lett       Date:  2017-05-09       Impact factor: 4.372

3.  Nebivolol elicits a neuroprotective effect in the cuprizone model of multiple sclerosis in mice: emphasis on M1/M2 polarization and inhibition of NLRP3 inflammasome activation.

Authors:  Antoinette G Naeem; Reem N El-Naga; Haidy E Michel
Journal:  Inflammopharmacology       Date:  2022-08-10       Impact factor: 5.093

4.  Biochemical and Functional Analysis of Cyanobacterium Geitlerinema sp. LPS on Human Monocytes.

Authors:  Michelle Swanson-Mungerson; Philip Williams; Joshua R Gurr; Ryan Incrocci; Vijay Subramaniam; Kinga Radowska; Mary L Hall; Alejandro M S Mayer
Journal:  Toxicol Sci       Date:  2019-07-04       Impact factor: 4.109

5.  Cyanobacteria Scytonema javanicum and Scytonema ocellatum Lipopolysaccharides Elicit Release of Superoxide Anion, Matrix-Metalloproteinase-9, Cytokines and Chemokines by Rat Microglia In Vitro.

Authors:  Lucas C Klemm; Evan Czerwonka; Mary L Hall; Philip G Williams; Alejandro M S Mayer
Journal:  Toxins (Basel)       Date:  2018-03-21       Impact factor: 4.546

Review 6.  Marine Pharmacology in 2012-2013: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis, and Antiviral Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous Mechanisms of Action.

Authors:  Alejandro M S Mayer; Abimael D Rodríguez; Orazio Taglialatela-Scafati; Nobuhiro Fusetani
Journal:  Mar Drugs       Date:  2017-08-29       Impact factor: 5.118

7.  Classical and Alternative Activation of Rat Microglia Treated with Ultrapure Porphyromonas gingivalis Lipopolysaccharide In Vitro.

Authors:  Zylfi Memedovski; Evan Czerwonka; Jin Han; Joshua Mayer; Margaret Luce; Lucas C Klemm; Mary L Hall; Alejandro M S Mayer
Journal:  Toxins (Basel)       Date:  2020-05-19       Impact factor: 4.546

8.  Lipopolysaccharides from Microcystis Cyanobacteria-Dominated Water Bloom and from Laboratory Cultures Trigger Human Immune Innate Response.

Authors:  Zdena Moosová; Lenka Šindlerová; Barbora Ambrůzová; Gabriela Ambrožová; Ondřej Vašíček; Mirna Velki; Pavel Babica; Lukáš Kubala
Journal:  Toxins (Basel)       Date:  2019-04-11       Impact factor: 4.546

9.  Oxycodone ameliorates the inflammatory response induced by lipopolysaccharide in primary microglia.

Authors:  Jishi Ye; Hong Yan; Zhongyuan Xia
Journal:  J Pain Res       Date:  2018-06-22       Impact factor: 3.133

10.  Intravenous Administration of Bone Marrow-Derived Mesenchymal Stem Cell, but not Adipose Tissue-Derived Stem Cell, Ameliorated the Neonatal Hypoxic-Ischemic Brain Injury by Changing Cerebral Inflammatory State in Rat.

Authors:  Yuichiro Sugiyama; Yoshiaki Sato; Yuma Kitase; Toshihiko Suzuki; Taiki Kondo; Alkisti Mikrogeorgiou; Asuka Horinouchi; Shoichi Maruyama; Yoshie Shimoyama; Masahiro Tsuji; Satoshi Suzuki; Tokunori Yamamoto; Masahiro Hayakawa
Journal:  Front Neurol       Date:  2018-09-11       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.